 | • レポートコード：GIR201105825 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、ノシセプチン受容体の世界市場を調査対象にし、ノシセプチン受容体の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（AT-403、BTRX-246040、セブラノパドール、GRT-6010、GRTTA-2210、その他）、用途別分析（糖尿病性神経障害性疼痛、薬物中毒、大うつ病性障害、帯状疱疹後神経痛、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Blackthorn Therapeutics Inc、Orexigen Therapeutics Inc、Fuso Pharmaceutical Industries Ltd、Grunenthal GmbH、Serodus ASA ・メーカー別販売量、売上、市場シェア ・ノシセプチン受容体の地域別市場分析 ・ノシセプチン受容体の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・ノシセプチン受容体のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・ノシセプチン受容体のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・ノシセプチン受容体の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・ノシセプチン受容体の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・ノシセプチン受容体の種類別市場規模2015-2020：AT-403、BTRX-246040、セブラノパドール、GRT-6010、GRTTA-2210、その他 ・ノシセプチン受容体の用途別市場規模2015-2020：糖尿病性神経障害性疼痛、薬物中毒、大うつ病性障害、帯状疱疹後神経痛、その他 ・ノシセプチン受容体の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Nociceptin Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Nociceptin Receptor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Nociceptin Receptor market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Nociceptin Receptor market has been segmented into
AT-403
BTRX-246040
Cebranopadol
GRT-6010
GRTTA-2210
Others
By Application, Nociceptin Receptor has been segmented into:
Diabetic Neuropathic Pain
Drug Addiction
Major Depressive Disorder
Postherpetic Neuralgia
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Nociceptin Receptor market presented in the report. This section sheds light on the sales growth of different regional and country-level Nociceptin Receptor markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Nociceptin Receptor market.
The report offers in-depth assessment of the growth and other aspects of the Nociceptin Receptor market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Nociceptin Receptor Market Share Analysis
Nociceptin Receptor competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Nociceptin Receptor sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Nociceptin Receptor sales, revenue and market share for each player covered in this report.
The major players covered in Nociceptin Receptor are:
Blackthorn Therapeutics Inc
Orexigen Therapeutics Inc
Fuso Pharmaceutical Industries Ltd
Grunenthal GmbH
Serodus ASA
Among other players domestic and global, Nociceptin Receptor market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nociceptin Receptor product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nociceptin Receptor, with price, sales, revenue and global market share of Nociceptin Receptor in 2018 and 2019.
Chapter 3, the Nociceptin Receptor competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nociceptin Receptor breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Nociceptin Receptor market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Nociceptin Receptor sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Nociceptin Receptor Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nociceptin Receptor Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 AT-403
1.2.3 BTRX-246040
1.2.4 Cebranopadol
1.2.5 GRT-6010
1.2.6 GRTTA-2210
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Nociceptin Receptor Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Diabetic Neuropathic Pain
1.3.3 Drug Addiction
1.3.4 Major Depressive Disorder
1.3.5 Postherpetic Neuralgia
1.3.6 Others
1.4 Overview of Global Nociceptin Receptor Market
1.4.1 Global Nociceptin Receptor Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Blackthorn Therapeutics Inc
2.1.1 Blackthorn Therapeutics Inc Details
2.1.2 Blackthorn Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Blackthorn Therapeutics Inc SWOT Analysis
2.1.4 Blackthorn Therapeutics Inc Product and Services
2.1.5 Blackthorn Therapeutics Inc Nociceptin Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Orexigen Therapeutics Inc
2.2.1 Orexigen Therapeutics Inc Details
2.2.2 Orexigen Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Orexigen Therapeutics Inc SWOT Analysis
2.2.4 Orexigen Therapeutics Inc Product and Services
2.2.5 Orexigen Therapeutics Inc Nociceptin Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Fuso Pharmaceutical Industries Ltd
2.3.1 Fuso Pharmaceutical Industries Ltd Details
2.3.2 Fuso Pharmaceutical Industries Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Fuso Pharmaceutical Industries Ltd SWOT Analysis
2.3.4 Fuso Pharmaceutical Industries Ltd Product and Services
2.3.5 Fuso Pharmaceutical Industries Ltd Nociceptin Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Grunenthal GmbH
2.4.1 Grunenthal GmbH Details
2.4.2 Grunenthal GmbH Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Grunenthal GmbH SWOT Analysis
2.4.4 Grunenthal GmbH Product and Services
2.4.5 Grunenthal GmbH Nociceptin Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Serodus ASA
2.5.1 Serodus ASA Details
2.5.2 Serodus ASA Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Serodus ASA SWOT Analysis
2.5.4 Serodus ASA Product and Services
2.5.5 Serodus ASA Nociceptin Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Nociceptin Receptor Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Nociceptin Receptor Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Nociceptin Receptor Manufacturer Market Share in 2019
3.3.2 Top 6 Nociceptin Receptor Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Nociceptin Receptor Sales, Revenue and Market Share by Regions
4.1.1 Global Nociceptin Receptor Sales and Market Share by Regions (2015-2020)
4.1.2 Global Nociceptin Receptor Revenue and Market Share by Regions (2015-2020)
4.2 North America Nociceptin Receptor Sales and Growth Rate (2015-2020)
4.3 Europe Nociceptin Receptor Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Nociceptin Receptor Sales and Growth Rate (2015-2020)
4.5 South America Nociceptin Receptor Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Nociceptin Receptor Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Nociceptin Receptor Sales, Revenue and Market Share by Country
5.1.1 North America Nociceptin Receptor Sales and Market Share by Country (2015-2020)
5.1.2 North America Nociceptin Receptor Revenue and Market Share by Country (2015-2020)
5.2 United States Nociceptin Receptor Sales and Growth Rate (2015-2020)
5.3 Canada Nociceptin Receptor Sales and Growth Rate (2015-2020)
5.4 Mexico Nociceptin Receptor Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Nociceptin Receptor Sales, Revenue and Market Share by Country
6.1.1 Europe Nociceptin Receptor Sales and Market Share by Country (2015-2020)
6.1.2 Europe Nociceptin Receptor Revenue and Market Share by Country (2015-2020)
6.2 Germany Nociceptin Receptor Sales and Growth Rate (2015-2020)
6.3 UK Nociceptin Receptor Sales and Growth Rate (2015-2020)
6.4 France Nociceptin Receptor Sales and Growth Rate (2015-2020)
6.5 Russia Nociceptin Receptor Sales and Growth Rate (2015-2020)
6.6 Italy Nociceptin Receptor Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Nociceptin Receptor Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Nociceptin Receptor Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Nociceptin Receptor Revenue and Market Share by Regions (2015-2020)
7.2 China Nociceptin Receptor Sales and Growth Rate (2015-2020)
7.3 Japan Nociceptin Receptor Sales and Growth Rate (2015-2020)
7.4 Korea Nociceptin Receptor Sales and Growth Rate (2015-2020)
7.5 India Nociceptin Receptor Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Nociceptin Receptor Sales and Growth Rate (2015-2020)
7.7 Australia Nociceptin Receptor Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Nociceptin Receptor Sales, Revenue and Market Share by Country
8.1.1 South America Nociceptin Receptor Sales and Market Share by Country (2015-2020)
8.1.2 South America Nociceptin Receptor Revenue and Market Share by Country (2015-2020)
8.2 Brazil Nociceptin Receptor Sales and Growth Rate (2015-2020)
8.3 Argentina Nociceptin Receptor Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Nociceptin Receptor Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Nociceptin Receptor Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Nociceptin Receptor Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Nociceptin Receptor Sales and Growth Rate (2015-2020)
9.3 Turkey Nociceptin Receptor Sales and Growth Rate (2015-2020)
9.4 Egypt Nociceptin Receptor Sales and Growth Rate (2015-2020)
9.5 South Africa Nociceptin Receptor Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Nociceptin Receptor Sales and Market Share by Type (2015-2020)
10.2 Global Nociceptin Receptor Revenue and Market Share by Type (2015-2020)
10.3 Global Nociceptin Receptor Price by Type (2015-2020)
11 Global Nociceptin Receptor Market Segment by Application
11.1 Global Nociceptin Receptor Sales Market Share by Application (2015-2020)
11.2 Global Nociceptin Receptor Revenue Market Share by Application (2015-2020)
11.3 Global Nociceptin Receptor Price by Application (2015-2020)
12 Market Forecast
12.1 Global Nociceptin Receptor Sales, Revenue and Growth Rate (2021-2025)
12.2 Nociceptin Receptor Market Forecast by Regions (2021-2025)
12.2.1 North America Nociceptin Receptor Market Forecast (2021-2025)
12.2.2 Europe Nociceptin Receptor Market Forecast (2021-2025)
12.2.3 Asia-Pacific Nociceptin Receptor Market Forecast (2021-2025)
12.2.4 South America Nociceptin Receptor Market Forecast (2021-2025)
12.2.5 Middle East & Africa Nociceptin Receptor Market Forecast (2021-2025)
12.3 Nociceptin Receptor Market Forecast by Type (2021-2025)
12.3.1 Global Nociceptin Receptor Sales Forecast by Type (2021-2025)
12.3.2 Global Nociceptin Receptor Market Share Forecast by Type (2021-2025)
12.4 Nociceptin Receptor Market Forecast by Application (2021-2025)
12.4.1 Global Nociceptin Receptor Sales Forecast by Application (2021-2025)
12.4.2 Global Nociceptin Receptor Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Nociceptin Receptor Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Nociceptin Receptor by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Nociceptin Receptor Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Blackthorn Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 8. Blackthorn Therapeutics Inc Nociceptin Receptor Major Business
Table 9. Blackthorn Therapeutics Inc Nociceptin Receptor Total Revenue (USD Million) (2018-2019)
Table 10. Blackthorn Therapeutics Inc SWOT Analysis
Table 11. Blackthorn Therapeutics Inc Nociceptin Receptor Product and Services
Table 12. Blackthorn Therapeutics Inc Nociceptin Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Orexigen Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 14. Orexigen Therapeutics Inc Nociceptin Receptor Major Business
Table 15. Orexigen Therapeutics Inc Nociceptin Receptor Total Revenue (USD Million) (2018-2019)
Table 16. Orexigen Therapeutics Inc SWOT Analysis
Table 17. Orexigen Therapeutics Inc Nociceptin Receptor Product and Services
Table 18. Orexigen Therapeutics Inc Nociceptin Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Fuso Pharmaceutical Industries Ltd Basic Information, Manufacturing Base and Competitors
Table 20. Fuso Pharmaceutical Industries Ltd Nociceptin Receptor Major Business
Table 21. Fuso Pharmaceutical Industries Ltd Nociceptin Receptor Total Revenue (USD Million) (2018-2019)
Table 22. Fuso Pharmaceutical Industries Ltd SWOT Analysis
Table 23. Fuso Pharmaceutical Industries Ltd Nociceptin Receptor Product and Services
Table 24. Fuso Pharmaceutical Industries Ltd Nociceptin Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Grunenthal GmbH Basic Information, Manufacturing Base and Competitors
Table 26. Grunenthal GmbH Nociceptin Receptor Major Business
Table 27. Grunenthal GmbH Nociceptin Receptor Total Revenue (USD Million) (2018-2019)
Table 28. Grunenthal GmbH SWOT Analysis
Table 29. Grunenthal GmbH Nociceptin Receptor Product and Services
Table 30. Grunenthal GmbH Nociceptin Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Serodus ASA Basic Information, Manufacturing Base and Competitors
Table 32. Serodus ASA Nociceptin Receptor Major Business
Table 33. Serodus ASA Nociceptin Receptor Total Revenue (USD Million) (2018-2019)
Table 34. Serodus ASA SWOT Analysis
Table 35. Serodus ASA Nociceptin Receptor Product and Services
Table 36. Serodus ASA Nociceptin Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Nociceptin Receptor Sales by Manufacturer (2018-2019) (K Pcs)
Table 38. Global Nociceptin Receptor Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Nociceptin Receptor Sales by Regions (2015-2020) (K Pcs)
Table 40. Global Nociceptin Receptor Sales Market Share by Regions (2015-2020)
Table 41. Global Nociceptin Receptor Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Nociceptin Receptor Sales by Countries (2015-2020) (K Pcs)
Table 43. North America Nociceptin Receptor Sales Market Share by Countries (2015-2020)
Table 44. North America Nociceptin Receptor Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Nociceptin Receptor Revenue Market Share by Countries (2015-2020)
Table 46. Europe Nociceptin Receptor Sales by Countries (2015-2020) (K Pcs)
Table 47. Europe Nociceptin Receptor Sales Market Share by Countries (2015-2020)
Table 48. Europe Nociceptin Receptor Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Nociceptin Receptor Sales by Regions (2015-2020) (K Pcs)
Table 50. Asia-Pacific Nociceptin Receptor Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Nociceptin Receptor Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Nociceptin Receptor Sales by Countries (2015-2020) (K Pcs)
Table 53. South America Nociceptin Receptor Sales Market Share by Countries (2015-2020)
Table 54. South America Nociceptin Receptor Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Nociceptin Receptor Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Nociceptin Receptor Sales by Countries (2015-2020) (K Pcs)
Table 57. Middle East & Africa Nociceptin Receptor Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Nociceptin Receptor Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Nociceptin Receptor Revenue Market Share by Countries (2015-2020)
Table 60. Global Nociceptin Receptor Sales by Type (2015-2020) (K Pcs)
Table 61. Global Nociceptin Receptor Sales Share by Type (2015-2020)
Table 62. Global Nociceptin Receptor Revenue by Type (2015-2020) (USD Million)
Table 63. Global Nociceptin Receptor Revenue Share by Type (2015-2020)
Table 64. Global Nociceptin Receptor Sales by Application (2015-2020) (K Pcs)
Table 65. Global Nociceptin Receptor Sales Share by Application (2015-2020)
Table 66. Global Nociceptin Receptor Sales Forecast by Regions (2021-2025) (K Pcs)
Table 67. Global Nociceptin Receptor Market Share Forecast by Regions (2021-2025)
Table 68. Global Nociceptin Receptor Sales Forecast by Type (2021-2025) (K Pcs)
Table 69. Global Nociceptin Receptor Market Share Forecast by Type (2021-2025)
Table 70. Global Nociceptin Receptor Sales Forecast by Application (2021-2025)
Table 71. Global Nociceptin Receptor Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Nociceptin Receptor Picture
Figure 2. Global Sales Market Share of Nociceptin Receptor by Type in 2019
Figure 3. AT-403 Picture
Figure 4. BTRX-246040 Picture
Figure 5. Cebranopadol Picture
Figure 6. GRT-6010 Picture
Figure 7. GRTTA-2210 Picture
Figure 8. Others Picture
Figure 9. Nociceptin Receptor Sales Market Share by Application in 2018
Figure 10. Diabetic Neuropathic Pain Picture
Figure 11. Drug Addiction Picture
Figure 12. Major Depressive Disorder Picture
Figure 13. Postherpetic Neuralgia Picture
Figure 14. Others Picture
Figure 15. Global Nociceptin Receptor Market Status and Outlook (2015-2025) (USD Million)
Figure 16. United States Nociceptin Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Canada Nociceptin Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Mexico Nociceptin Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Germany Nociceptin Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 20. France Nociceptin Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 21. UK Nociceptin Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Russia Nociceptin Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Italy Nociceptin Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 24. China Nociceptin Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Japan Nociceptin Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Korea Nociceptin Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 27. India Nociceptin Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Southeast Asia Nociceptin Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Australia Nociceptin Receptor Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 30. Brazil Nociceptin Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Egypt Nociceptin Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Saudi Arabia Nociceptin Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 33. South Africa Nociceptin Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Turkey Nociceptin Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 35. Global Nociceptin Receptor Sales Market Share by Manufacturer in 2019
Figure 36. Global Nociceptin Receptor Revenue Market Share by Manufacturer in 2019
Figure 37. Top 3 Nociceptin Receptor Manufacturer (Revenue) Market Share in 2019
Figure 38. Top 6 Nociceptin Receptor Manufacturer (Revenue) Market Share in 2019
Figure 39. Key Manufacturer Market Share Trend
Figure 40. Global Nociceptin Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 41. Global Nociceptin Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 42. Global Nociceptin Receptor Revenue Market Share by Regions (2015-2020)
Figure 43. Global Nociceptin Receptor Revenue Market Share by Regions in 2018
Figure 44. North America Nociceptin Receptor Sales and Growth Rate (2015-2020)
Figure 45. Europe Nociceptin Receptor Sales and Growth Rate (2015-2020)
Figure 46. Asia-Pacific Nociceptin Receptor Sales and Growth Rate (2015-2020)
Figure 47. South America Nociceptin Receptor Sales and Growth Rate (2015-2020)
Figure 48. Middle East & Africa Nociceptin Receptor Sales and Growth Rate (2015-2020)
Figure 49. North America Nociceptin Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 50. North America Nociceptin Receptor Sales Market Share by Countries (2015-2020)
Figure 51. North America Nociceptin Receptor Sales Market Share by Countries in 2018
Figure 52. North America Nociceptin Receptor Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 53. North America Nociceptin Receptor Revenue Market Share by Countries in 2018
Figure 54. United States Nociceptin Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Canada Nociceptin Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Mexico Nociceptin Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. Europe Nociceptin Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 58. Europe Nociceptin Receptor Revenue Market Share by Countries (2015-2020)
Figure 59. Europe Nociceptin Receptor Revenue Market Share by Countries in 2019
Figure 60. Germany Nociceptin Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. UK Nociceptin Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. France Nociceptin Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Russia Nociceptin Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Italy Nociceptin Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Asia-Pacific Nociceptin Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 66. Asia-Pacific Nociceptin Receptor Sales Market Share by Regions 2019
Figure 67. Asia-Pacific Nociceptin Receptor Revenue Market Share by Regions 2019
Figure 68. China Nociceptin Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Japan Nociceptin Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. Korea Nociceptin Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. India Nociceptin Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. Southeast Asia Nociceptin Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. South America Nociceptin Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. South America Nociceptin Receptor Sales Market Share by Countries in 2019
Figure 75. South America Nociceptin Receptor Revenue Market Share by Countries in 2019
Figure 76. Brazil Nociceptin Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Argentina Nociceptin Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 78. Middle East and Africa Nociceptin Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 79. Middle East and Africa Nociceptin Receptor Sales Market Share by Countries in 2019
Figure 80. Middle East and Africa Nociceptin Receptor Revenue Market Share by Countries (2015-2020)
Figure 81. Middle East and Africa Nociceptin Receptor Revenue Market Share by Countries in 2019
Figure 82. Saudi Arabia Nociceptin Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Egypt Nociceptin Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. Turkey Nociceptin Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. South Africa Nociceptin Receptor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 86. Global Nociceptin Receptor Sales and Growth Rate (2021-2025) (K Pcs)
Figure 87. Global Nociceptin Receptor Revenue and Growth Rate (2021-2025) (USD Million)
Figure 88. North America Sales Nociceptin Receptor Market Forecast (2021-2025) (K Pcs)
Figure 89. Europe Sales Nociceptin Receptor Market Forecast (2021-2025) (K Pcs)
Figure 90. Asia-Pacific Sales Nociceptin Receptor Market Forecast (2021-2025) (K Pcs)
Figure 91. South America Sales Nociceptin Receptor Market Forecast (2021-2025) (K Pcs)
Figure 92. Middle East & Africa Sales Nociceptin Receptor Market Forecast (2021-2025) (K Pcs)
Figure 93. Sales Channel: Direct Channel vs Indirect Channel
アルファ2Cアドレナリン受容体の世界市場 2020年 Market Overview The global Alpha 2C Adrenergic Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Alpha 2C Adrener…- C-X-Cケモカイン受容体タイプ1の世界市場 2020年 Market Overview The global C-X-C Chemokine Receptor Type 1 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The C-X-C Chemoki…
- GABA受容体作動薬の世界市場 2020年 Market Overview The global GABA Receptor Agonist Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The GABA Receptor Agon…
- プロスタグランジンE2受容体EP4サブタイプの世界市場 2020年 Market Overview The global Prostaglandin E2 Receptor EP4 Subtype market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prostag…
- ソマトスタチン受容体4型の世界市場 2020年 Market Overview The global Somatostatin Receptor Type 4 market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Somatostatin Rec…